Logo image of ALMIB.PA

AMOEBA SAS (ALMIB.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALMIB - FR0011051598 - Common Stock

0.965 EUR
-0.01 (-0.62%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

0

ALMIB gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 74 industry peers in the Chemicals industry. Both the profitability and financial health of ALMIB have multiple concerns. ALMIB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALMIB had negative earnings in the past year.
In the past year ALMIB has reported a negative cash flow from operations.
In the past 5 years ALMIB always reported negative net income.
ALMIB had a negative operating cash flow in each of the past 5 years.
ALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

With a Return On Assets value of -115.55%, ALMIB is not doing good in the industry: 95.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -115.55%
ROE N/A
ROIC N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMIB.PA Yearly ROA, ROE, ROICALMIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALMIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMIB.PA Yearly Profit, Operating, Gross MarginsALMIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ALMIB has been increased compared to 1 year ago.
The number of shares outstanding for ALMIB has been increased compared to 5 years ago.
Compared to 1 year ago, ALMIB has a worse debt to assets ratio.
ALMIB.PA Yearly Shares OutstandingALMIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALMIB.PA Yearly Total Debt VS Total AssetsALMIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALMIB has an Altman-Z score of -8.64. This is a bad value and indicates that ALMIB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALMIB (-8.64) is worse than 91.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.64
ROIC/WACCN/A
WACCN/A
ALMIB.PA Yearly LT Debt VS Equity VS FCFALMIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ALMIB has a Current Ratio of 0.28. This is a bad value and indicates that ALMIB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALMIB (0.28) is worse than 95.95% of its industry peers.
A Quick Ratio of 0.25 indicates that ALMIB may have some problems paying its short term obligations.
ALMIB's Quick ratio of 0.25 is on the low side compared to the rest of the industry. ALMIB is outperformed by 95.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.25
ALMIB.PA Yearly Current Assets VS Current LiabilitesALMIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

ALMIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.43%, which is quite impressive.
EPS 1Y (TTM)47.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ALMIB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.50% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y8.71%
EPS Next 2Y5.26%
EPS Next 3Y21.16%
EPS Next 5Y31.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMIB.PA Yearly Revenue VS EstimatesALMIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
ALMIB.PA Yearly EPS VS EstimatesALMIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALMIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMIB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMIB.PA Price Earnings VS Forward Price EarningsALMIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMIB.PA Per share dataALMIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMIB's earnings are expected to grow with 21.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.26%
EPS Next 3Y21.16%

More info and screens

0

5. Dividend

5.1 Amount

ALMIB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMOEBA SAS

EPA:ALMIB (11/28/2025, 7:00:00 PM)

0.965

-0.01 (-0.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-03 2025-10-03
Earnings (Next)03-25 2026-03-25
Inst Owners0.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap66.51M
Revenue(TTM)N/A
Net Income(TTM)-7.36M
Analysts85.45
Price Target1.53 (58.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)4.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-33.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -115.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-136.25%
ROA(5y)-104.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 217.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.25
Altman-Z -8.64
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)289.55%
Cap/Depr(5y)177.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.52%
EPS Next Y8.71%
EPS Next 2Y5.26%
EPS Next 3Y21.16%
EPS Next 5Y31.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.68%
EBIT Next 3Y24.86%
EBIT Next 5YN/A
FCF growth 1Y-8.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.23%
OCF growth 3YN/A
OCF growth 5YN/A

AMOEBA SAS / ALMIB.PA FAQ

Can you provide the ChartMill fundamental rating for AMOEBA SAS?

ChartMill assigns a fundamental rating of 0 / 10 to ALMIB.PA.


Can you provide the valuation status for AMOEBA SAS?

ChartMill assigns a valuation rating of 1 / 10 to AMOEBA SAS (ALMIB.PA). This can be considered as Overvalued.


What is the profitability of ALMIB stock?

AMOEBA SAS (ALMIB.PA) has a profitability rating of 0 / 10.


What is the financial health of AMOEBA SAS (ALMIB.PA) stock?

The financial health rating of AMOEBA SAS (ALMIB.PA) is 0 / 10.


What is the expected EPS growth for AMOEBA SAS (ALMIB.PA) stock?

The Earnings per Share (EPS) of AMOEBA SAS (ALMIB.PA) is expected to grow by 8.71% in the next year.